MX2010002113A - Metodos para detectar oligonucleotidos. - Google Patents

Metodos para detectar oligonucleotidos.

Info

Publication number
MX2010002113A
MX2010002113A MX2010002113A MX2010002113A MX2010002113A MX 2010002113 A MX2010002113 A MX 2010002113A MX 2010002113 A MX2010002113 A MX 2010002113A MX 2010002113 A MX2010002113 A MX 2010002113A MX 2010002113 A MX2010002113 A MX 2010002113A
Authority
MX
Mexico
Prior art keywords
methods
oligonucleotides
detecting
compositions
detecting oligonucleotides
Prior art date
Application number
MX2010002113A
Other languages
English (en)
Inventor
Francois Jean-Charles Natt
Iwan Beuvink
Andrew Geall
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2010002113A publication Critical patent/MX2010002113A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/204—Modifications characterised by specific length of the oligonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La invención proporciona métodos y composiciones para detectar y/o cuantificar oligonucleótidos de ácidos nucleicos. Estos métodos y composiciones son útiles para detectar y cuantificar los oligonucleótidos objetivo sintéticos de diagnóstico y/o terapéuticos, tales como aptámeros, ARNi, siARN, oligonucleótidos anti-sentido, ó ribozimas en una muestra biológica.
MX2010002113A 2007-08-23 2008-08-21 Metodos para detectar oligonucleotidos. MX2010002113A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95748707P 2007-08-23 2007-08-23
PCT/EP2008/060948 WO2009024599A1 (en) 2007-08-23 2008-08-21 Methods for detecting oligonucleotides

Publications (1)

Publication Number Publication Date
MX2010002113A true MX2010002113A (es) 2010-03-26

Family

ID=40076846

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010002113A MX2010002113A (es) 2007-08-23 2008-08-21 Metodos para detectar oligonucleotidos.

Country Status (9)

Country Link
US (1) US20110097716A1 (es)
EP (1) EP2183390A1 (es)
KR (1) KR20100063079A (es)
CN (1) CN101835903A (es)
AU (1) AU2008290545A1 (es)
BR (1) BRPI0815725A2 (es)
CA (1) CA2695420A1 (es)
MX (1) MX2010002113A (es)
WO (1) WO2009024599A1 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2600901B1 (en) 2010-08-06 2019-03-27 ModernaTX, Inc. A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
ES2737960T3 (es) 2010-10-01 2020-01-17 Modernatx Inc Nucleósidos, nucleótidos y ácidos nucleicos modificados y sus usos
AU2012236099A1 (en) 2011-03-31 2013-10-03 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
WO2012149042A2 (en) 2011-04-25 2012-11-01 Bio-Rad Laboratories, Inc. Methods and compositions for nucleic acid analysis
TR201910686T4 (tr) 2011-06-08 2019-08-21 Translate Bio Inc Mrna iletimine yönelik lipit nanopartikül bileşimleri ve yöntemler.
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
EP3682905B1 (en) 2011-10-03 2021-12-01 ModernaTX, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
EP2791160B1 (en) 2011-12-16 2022-03-02 ModernaTX, Inc. Modified mrna compositions
EP2802674B1 (en) 2012-01-11 2020-12-16 Ionis Pharmaceuticals, Inc. Compositions and methods for modulation of ikbkap splicing
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9303079B2 (en) 2012-04-02 2016-04-05 Moderna Therapeutics, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
AU2013243948A1 (en) 2012-04-02 2014-10-30 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins associated with human disease
EP4074834A1 (en) 2012-11-26 2022-10-19 ModernaTX, Inc. Terminally modified rna
WO2014137329A1 (en) 2013-03-05 2014-09-12 Agilent Technologies, Inc. Synthesis of pools of probes by primer extension
WO2014145620A2 (en) * 2013-03-15 2014-09-18 The Broad Institute, Inc. Novel hybridization probes and uses thereof
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
WO2015048744A2 (en) 2013-09-30 2015-04-02 Moderna Therapeutics, Inc. Polynucleotides encoding immune modulating polypeptides
CA2926218A1 (en) 2013-10-03 2015-04-09 Moderna Therapeutics, Inc. Polynucleotides encoding low density lipoprotein receptor
US11162096B2 (en) * 2013-10-14 2021-11-02 Ionis Pharmaceuticals, Inc Methods for modulating expression of C9ORF72 antisense transcript
EP3334499A4 (en) * 2015-08-14 2019-04-17 University of Massachusetts BIOACTIVE CONJUGATES FOR THE RELEASE OF OLIGONUCLEOTIDES
PT3350157T (pt) 2015-09-17 2022-03-18 Modernatx Inc Compostos e composições para administração intracelular de agentes terapêuticos
EP3964200A1 (en) 2015-12-10 2022-03-09 ModernaTX, Inc. Compositions and methods for delivery of therapeutic agents
AU2016377681B2 (en) 2015-12-22 2021-05-13 Modernatx, Inc. Compounds and compositions for intracellular delivery of agents
US9617587B1 (en) * 2016-04-04 2017-04-11 Nat Diagnostics, Inc. Isothermal amplification components and processes
CA3039068A1 (en) * 2016-10-07 2018-04-12 Secarna Pharmaceuticals Gmbh & Co. Kg Immunosuppression-reverting oligonucleotides inhibiting the expression of cd39
WO2018089540A1 (en) 2016-11-08 2018-05-17 Modernatx, Inc. Stabilized formulations of lipid nanoparticles
US11085071B2 (en) * 2017-02-01 2021-08-10 Spot Biosystems Ltd. Highly stable and specific molecular beacons encapsulated in cationic lipoplex nanoparticles and application thereof
ES2911186T3 (es) 2017-03-15 2022-05-18 Modernatx Inc Formas cristalinas de aminolípidos
PL3596041T3 (pl) 2017-03-15 2023-03-06 Modernatx, Inc. Związek i kompozycje do dokomórkowego dostarczania środków terapeutycznych
US11969506B2 (en) 2017-03-15 2024-04-30 Modernatx, Inc. Lipid nanoparticle formulation
US11786607B2 (en) 2017-06-15 2023-10-17 Modernatx, Inc. RNA formulations
WO2019046809A1 (en) 2017-08-31 2019-03-07 Modernatx, Inc. METHODS OF MANUFACTURING LIPID NANOPARTICLES
EP3906317A1 (en) * 2019-01-03 2021-11-10 DNA Script One pot synthesis of sets of oligonucleotides
CN109913534A (zh) * 2019-01-24 2019-06-21 中国药科大学 一种基于级联DNA链循环反应和荧光共振能量转移效应的两种miRNA同时检测的方法
CN109868309B (zh) * 2019-03-05 2022-11-11 苏州恩可医药科技有限公司 基于通用碱基替换插入的单链dna扩增方法
AR120080A1 (es) 2019-09-19 2022-02-02 Modernatx Inc Compuestos lipídicos de cola ramificada y composiciones para la administración intracelular de agentes terapéuticos
CN111500676B (zh) * 2020-04-21 2022-09-09 桂林旅游学院 一种将寡聚核苷酸逆转录成cDNA的方法及寡聚核苷酸检测方法
US11524023B2 (en) 2021-02-19 2022-12-13 Modernatx, Inc. Lipid nanoparticle compositions and methods of formulating the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7575863B2 (en) * 2004-05-28 2009-08-18 Applied Biosystems, Llc Methods, compositions, and kits comprising linker probes for quantifying polynucleotides
US20060057595A1 (en) * 2004-09-16 2006-03-16 Applera Corporation Compositions, methods, and kits for identifying and quantitating small RNA molecules
DE602006016739D1 (de) * 2005-01-25 2010-10-21 Rosetta Inpharmatics Llc Verfahren zur quantifizierung kleiner rna-moleküle

Also Published As

Publication number Publication date
US20110097716A1 (en) 2011-04-28
EP2183390A1 (en) 2010-05-12
BRPI0815725A2 (pt) 2015-02-10
CN101835903A (zh) 2010-09-15
CA2695420A1 (en) 2009-02-26
WO2009024599A1 (en) 2009-02-26
AU2008290545A1 (en) 2009-02-26
KR20100063079A (ko) 2010-06-10

Similar Documents

Publication Publication Date Title
MX2010002113A (es) Metodos para detectar oligonucleotidos.
WO2006012468A3 (en) Detection of oligonuleotides by dual hybridization
CY1121198T1 (el) Αντινοημaτικα μορια και μεθοδοι για την θεραπεια παθολογιων
IL275598B (en) A system for identifying bacteria in biological samples
WO2014182528A3 (en) Multiplex labeling of molecules by sequential hybridization barcoding
UA116205C2 (uk) Спосіб кількісного визначення послідовності нуклеїнової кислоти в зразку
WO2006029258A3 (en) Aptamer medicinal chemistry
EP2083269A4 (en) METHOD OF ASSAYING TARGET SUBSTANCE IN SAMPLE, APTAMER AND METHOD OF MANUFACTURING THE SAME
EP2126122A4 (en) METHOD AND TEST KIT FOR DETERMINING THE QUANTITIES OF TARGET SEQUENCES AND NUCLEOTIDE VARIATIONS THEREIN
WO2008061537A3 (en) Oligonucleotides for modulating target rna activity
EP1987166A4 (en) DEOXYRIBOZYME BINARY PROBES FOR ANALYSIS OF NUCLEIC ACID
CA2873099C (en) Aptamer-based multiplexed assays
GB2459228A (en) Exosome-associated microrna as a diagnostic marker
WO2012141844A3 (en) Methods predicting risk of an adverse clinical outcome
EP2305807A4 (en) PROCESS FOR DETECTING OR QUANTIFYING DNA
WO2010105275A3 (en) Method to assess human allograft status from microrna expression levels
WO2006076674A3 (en) Deprotection and purification of oligonucleotides and their derivatives
EP2305806A4 (en) PROCESS FOR DETECTING OR QUANTIFYING DNA
BRPI0811623A2 (pt) Métodos para identificar genes envolvidos na formação de memória usando pequeno rna interferente (sirna)
EP2075341A4 (en) METHOD FOR THE INVESTIGATION, DETERMINATION OR EVALUATION BY MEANS OF GENE EXPRESSION ANALYSIS
WO2007085497A3 (en) Markers for the prediction of outcome of anthracycline treatment
WO2013083098A3 (en) Method of determination of cancer cell drug sensitivity towards aurora kinase inhibitors
EP2569635A4 (en) METHODS OF DIAGNOSING AND TREATING ENCEPHALITY OR EPILEPSY
WO2010028373A3 (en) Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients
HK1211625A1 (en) Nucleic acids and methods for detecting turfgrass pathogenic fungi

Legal Events

Date Code Title Description
FA Abandonment or withdrawal